옵션 체인은 다양한 행사가격과 만기일에 대한 Genmab의 주식 옵션 주요 데이터를 보여줍니다. 트레이더들은 이 정보를 사용하여 잠재적 거래를 분석하고 Genmab에 대한 시장 심리를 평가합니다..

Genmab (NASDAQ:GMAB) 주식, 옵션 체인

Genmab

Genmab is a Copenhagen-based biotechnology company specializing in antibody therapeutics for the treatment of cancer. Genmab's proprietary antibody technologies are DuoBody, HexaBody, DuoHexaBody, and HexElect. Johnson & Johnson partnered with Genmab to create Darzalex, which is regarded as the standard of care for multiple myeloma and is Genmab's leading product. Genmab also has Tepezza for thyroid eye disease (partnered with Horizon), Kesimpta for relapsing multiple sclerosis (partnered with Novartis), Rybrevant (partnered with Johnson & Johnson) for non-small cell lung cancer (NSCLC), Tivdak (partnered with Seagen) for cervical cancer, and Epkinly (partnered with AbbVie) for diffuse large B-cell lymphoma. Genmab has several pipeline candidates targeting other oncologic indications.

Coinbase Photo by Useacoin on Shutterstock

Equities

Large Cap

News

Movers

Trading Ideas

AAPL

ADBE

COIN

EXPE

GMAB

HOOD

IBKR

SAIL

이들 대형 주식은 지난주에 최악의 성과를 보였다. 이 주식이 당신의 포트폴리오에 있나요? 1. 테라다인(NASDAQ:TER)의 주가가 20.08% 하락했다. 이 회사는 포토닉 IC 테스트 회사인 퀀티파이 포토닉스(Quantifi Photonics)를 비공개 금액에 인수하기로 합의했다. 애널리스트들은 이 회사의 가격 전망을 하향 조정했다.

코인베이스, 애플, 로빈후드 등 지난주 급락한 대형주 12종목 (3월 10일-3월 14일)

Genmab AS

Wells Fargo analyst Yanan Zhu maintains Metagenomi (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGX#NASDAQ">MGX</a>) with a Overweight and lowers the price target from $25 to $20.

Price Target

Analyst Ratings

Wells Fargo Maintains Overweight on Metagenomi, Lowers Price Target to $20

Wells Fargo analyst Zachary Fadem maintains RH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RH#NYSE">RH</a>) with a Overweight and lowers the price target from $500 to $375.

Wells Fargo Maintains Overweight on RH, Lowers Price Target to $375

<figure class="wp-block-image size-full is-resized"><img loading="lazy" decoding="async" width="900" height="600" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/03/18072303/Weibo-0318-01.jpeg" alt="" class="wp-image-8149" style="width:900px;height:auto" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/03/18072303/Weibo-0318-01.jpeg 900w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/03/18072303/Weibo-0318-01-300x200.jpeg 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/03/18072303/Weibo-0318-01-768x512.jpeg 768w" sizes="(max-width: 900px) 100vw, 900px" /></figure>
One of China's earliest social media companies said most of its major metrics were flat in its latest quarterly report, as it remains reliant on advertising for 85% of its revenue
<h4 class="wp-block-heading">Key Takeaways:</h4>
<ul>
<li>Weibo's revenue fell 1% in the fourth quarter, as a 4% drop in its core advertising business was partly offset by a rise in its smaller value-added services</li>
<li>More than half of the 21 analysts polled by Yahoo Finance rate the company a "hold" or worse, reflecting bearishness on its stock and ability to revive its prospects</li>
</ul>
Which way, Weibo?
Both analysts and investors seem undecided these days on&nbsp;Weibo Corp.&nbsp;(WB.US; 9898.HK), one of China's earliest and most enduring social media companies that started out as a knockoff of Twitter, now known as X. Many might argue that like X, Weibo is currently in need of a major overhaul, which might be better done out of the public eye as a private rather than publicly traded company.
Weibo's woes were on display in its&nbsp;<a href="https://www.prnewswire.com/news-releases/weibo-announces-fourth-quarter-and-fiscal-year-2024-unaudited-financial-results-and-annual-dividend-302400844.html">latest quarterly results</a>&nbsp;released last Thursday, which repeated a frequent refrain of recent years portraying a company mired in stagnation. All these years after first exploding on the scene after the original Twitter was blocked in China in 2009, Weibo still relies on advertising for the big majority of its revenue, accounting for 85% in the latest quarter.
That business has fallen flat these days, and was actually down 4% in the fourth quarter to $385.9 million from $403.7 million a year earlier. The company's overall revenue for the quarter was down by a milder 1% to $456.8 million from $463.7 million a year earlier, saved by an 18% rise in value-added services that are its other main revenue source.
The investment community's mixed feelings on this company are nicely reflected in its split profile among analysts. Of the 21 polled by Yahoo Finance, 10 rate Weibo a "hold," one gives it an "underperform" and one a "sell" – very bearish numbers that show many see little potential for a turnaround anytime soon, either in its business or its stock price. That said, there are still eight who rate it a "buy" and a lone cheerleader who gives it a "strong buy" – perhaps a relative of the company's longtime Chairman Charles Chao or its CEO Wang Gaofei.
To be fair, Weibo has been trying to diversify and compete with China's latest "in crowd" that has found gold in revenue streams like tipping for their favorite online celebrities, livestreaming e-commerce and the sale of virtual objects. But nothing seems to have worked, leaving Weibo as mostly a one-trick pony addicted to an online advertising market that has only grown more crowded with popular newcomers like Douyin and Xiaohongshu over time.
The company was led for years by Chairman Chao, who harkens from the first generation of internet entrepreneurs that also includes the likes of Alibaba's Jack Ma and Tencent's Pony Ma. But lately Chao has stepped back into a non-executive role and is letting a younger generation take over, led by current CEO Wang.
Still, the best Wang could do on the company's latest earnings call was detail which sectors are getting a boost from China's recent stimulus measures targeted at consumers, which is helping to boost ad spending by those sectors. He noted that digital products and e-commerce had gotten a boost from such stimulus, while most other areas, including beauty, personal care and luxury products, continue to suffer.
He also touted a new version of Weibo intelligent search using the latest open-source AI models that would be rolled out this quarter, following other Chinese companies in showing how the company is using the hot technology to advance its business.
<h4 class="wp-block-heading">Stagnation all around</h4>
We've already described how Weibo's revenue has entered a period of stagnation, and that's reflected in its other numbers as well. Its monthly active users fell slightly to 590 million in the fourth quarter from 598 million a year earlier. Its average daily active users ticked up slightly to 260 million from 257 million over that period.
The one major metric that wasn't flat was its net income, which plummeted to $8.9 million from $83.2 million a year earlier. But its non-GAAP profit, which typically excludes share-based compensation and other non-cash items, actually rose to $106.6 million from $76.4 million.
In a bid to keep investors interested, the company announced a new policy to pay a regular annual dividend, after paying two one-time dividends over the last two years. Its latest dividend will see it pay out $200 million for 2024, equal to $0.82 per American depositary share (ADS), which equals a fairly respectable 7.5% return based on its latest share price. So, if you're a dividend lover, perhaps this stock is for you. But if you like growth, you should probably look elsewhere.
Reflecting the mixed sentiment about the company, Weibo's stock dropped 3.2% on Thursday after the results were announced, but then gained all of that back and a little bit more over the next two trading days. Still, at its latest close of $10.90, the stock is 36% below the $17 it sold shares for when it was still quite a hot company at the time of its 2014 IPO.
Weibo's parent, Sina Corp., was one of China's earliest publicly traded internet companies and later privatized as a somewhat redundant entity after Weibo became its primary asset. Weibo looked set to follow that pattern in 2021, when reports emerged that Chairman Chao was in talks with an unnamed Shanghai-based state investor to privatize the company, in a deal that could have value it at about $20 billion.
Chao is probably wishing that deal had come to fruition, since Weibo's market cap has shrunk since then to just $2.7 billion. The stock has lost about 80% of its value since then amid a broader selloff for Chinese companies between 2021 and 2024. It has bounced back by about 50% over the last six months with the China stock rally, though this really seems like the case of the old adage that "a rising tide raises all ships" rather than any vote of confidence in Weibo.
Despite the rally, Weibo's stock trades at an anemic price-to-earnings (P/E) ratio of just 9, well behind the 25 for Facebook parent&nbsp;Meta&nbsp;(META.US) and 31 for domestic peer&nbsp;Tencent&nbsp;(0700.HK), owner of WeChat. Frankly speaking, Weibo could be past the point of saving, similar to the original X/Twitter, which also looks like a sinking ship. But for any chance of longer-term survival, a Twitter-like privatization and major overhaul of the company out of the public spotlight seems mandatory.

Asia

Earnings

Dividends

Tech

Dividend Investors May Like This Stock's 7.5% Yield

On Tuesday, SNDL Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNDL#NASDAQ">SNDL</a>) reported fourth-quarter sales of CA257.68 million, up 3.7% year over year, beating the <a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">consensus of CA248.10 million</a>.
Net revenue&nbsp;for 2024 was <a target="_blank" href="https://www.benzinga.com/cannabis" rel="noreferrer noopener">CA920.4 million, up 1.3%</a>.
The company says the quarter and the full year represent new records for the corporation, driven by strong growth from the combined cannabis business of +16.5% in the fourth quarter and +10.6% <a href="https://www.benzinga.com/pressreleases/25/03/n44373050/sndl-reports-fourth-quarter-and-full-year-2024-financial-and-operational-results" target="_blank" rel="noreferrer noopener">over the full year</a>.
Net revenue for liquor retail continued to decline in the fourth quarter to CA154.08 million, down 3.4%, although slightly slower than in previous quarters, amid market demand softness.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/01/42793407/cannabis-physician-surgeon-generals-alcohol-cancer-risk-warning-is-a-wake-up-call" rel="noreferrer noopener">EXCLUSIVE: Cannabis Physician Says Surgeon General&#8217;s Alcohol Cancer Risk Warning Is &#8216;Wake-Up Call&#8217;</a>
Same-store sales&nbsp;decreased by -3.5% in the fourth quarter and -4.6% for the full year.
&#8220;We are pleased with the continued progress reflected in our fourth-quarter and full-year 2024 results, as we set new records and exceeded our commitment to achieving break-even free cash flow for the year. We have accomplished this while continuing to transform our business by investing in growth opportunities and strengthening our organizational capabilities,&#8221; said Zach George, CEO of SNDL.
Net revenue for cannabis retail grew 10.7% to CA83.17 million as the Value Buds banner continues to gain market share. The company also conducted some additional promotional activities in the fourth quarter.
Same-store sales increased by +6.3% in the fourth quarter and +3.5% over the full year.
Cannabis operations reported a 42.4% jump in sales to CA37.09 million, driven by the increased provincial board and Business-to-Business distribution.
The cannabis company reported a gross profit&nbsp;of&nbsp;CA68.8 million&nbsp;in the fourth quarter of 2024 and&nbsp;CA240.3 million&nbsp;for 2024, representing growth of +20.0% and +26.2%, respectively.
SNDL reported an operating loss of CA76.1 million for the fourth quarter of 2024, driven by a negative valuation adjustment of the SunStream portfolio of CA65.7 million, a Spiritleaf intangible write-off of CA15.0 million and restructuring charges of CA0.6 million.
Cash flow&nbsp;was negative by&nbsp;$(44.6) million&nbsp;in the fourth quarter of 2024, driven by the acquisition of Nova&#8217;s minority equity interest and the repurchase of SNDL&#8217;s common shares.
Full-year cash flow was positive by&nbsp;$23.3 million. Free cash flow&nbsp;was positive in the fourth quarter at&nbsp;$11.6 million and $8.9 million for 2024.
Price Action: SNDL stock is up 4.52% at $1.62 during the premarket session at the last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44371971/rocket-lab-launches-final-kineis-satellites-enabling-global-iot-coverage" target="_blank" rel="noreferrer noopener">Rocket Lab Launches Final Kinéis Satellite, Enabling Global IoT Coverage</a></li>
</ul>
Photo: Shutterstock

Cannabis

General

SNDL

Canadian Cannabis SNDL Achieves Break-Even Free Cash Flow For 2024

Biotech

DWTX

Dogwood Doses First Patient In Phase 2b Trial Evaluating Halneuro

Barclays analyst Betty Jiang maintains Murphy Oil (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MUR#NYSE">MUR</a>) with a Equal-Weight and lowers the price target from $34 to $32.

Barclays Maintains Equal-Weight on Murphy Oil, Lowers Price Target to $32

MD Local Global Limited, a wholly owned subsidiary of&nbsp;MDJM LTD (NASDAQ:<a href="https://www.benzinga.com/stock/UOKA#NASDAQ">UOKA</a>) (the "Company" or "MDJM"), an integrated global culture-driven asset management company, today announced that it has signed an Architectural Design Service Agreement with the Japanese architectural firm KENGO KUMA &amp; ASSOCIATES, INC (KKAA). Since its establishment,&nbsp;KKAA has completed over 550 projects.&nbsp;This partnership is established to drive the Fernie Castle Oriental Landscape Project, which project is intended to harmonize traditional Eastern garden art with historic Scottish castle aesthetic, aiming to create a landmark that embodies both cultural richness and modern design.
Situated in the picturesque surroundings of Fife, Scotland, the 16th-century Fernie Castle is surrounded by 17 acres of woodlands, offering a serene, historic setting. The Oriental Landscape Project is anticipated to blend Eastern-inspired garden features with the castle's Western architectural heritage, which may serve as a global example of harmonizing diverse cultural designs.

UOKA

MDJM LTD's MD Local Global Announces That It Has Signed An Architectural Design Service Agreement With The Japanese Architectural Firm KENGO KUMA & ASSOCIATES

Tencent Music Entertainment Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TME#NYSE">TME</a>) shares are trading higher in<a target="_blank" href="https://www.benzinga.com/pressreleases/25/03/n44371396/tencent-music-entertainment-group-announces-fourth-quarter-and-full-year-2024-unaudited-financial-" rel="noreferrer noopener"> the premarket session on Tuesday.</a>
The company reported fourth-quarter revenues of $1.02 billion, beating the street view of $1.01 billion. Revenues increased 8.2% year over year, primarily due to strength in online music services, partially offset by a decline in revenues from social entertainment services and others.
China&#8217;s online music and audio entertainment platform&#8217;s adjusted EPADS of $0.20 (1.47 Chinese yuan) beat the consensus of $0.19.
Revenues from music subscriptions&nbsp;were&nbsp;$552 million, representing 18.0% year-over-year growth.
Net profit attributable to equity holders of the company&nbsp;was&nbsp;$268 million, representing 49.8% year-over-year growth.&nbsp;
Also Read: <a target="_blank" href="http://benzinga.com/media/25/03/44368717/chinas-deepseek-sparks-national-security-alarm-do-not-download-view-access-any-applications" rel="noreferrer noopener">China&#8217;s DeepSeek Sparks National Security Alarm: &#8216;Do Not Download, View, Access Any Applications&#8230;&#8217;</a>
Gross margin increased&nbsp;to 43.6% from 38.3% in the same period of 2023, primarily&nbsp;due to strong growth in revenues from music subscriptions, including&nbsp;subscriptions to SVIP membership.
Monthly active users (MAUs) for online music declined by 3.5% year over year to 556 million, and mobile MAUs for social entertainment decreased by 21.2% year over year to 82 million.
The monthly average revenue per user (ARPPU) for online music grew by 3.7% year over year to 11.1 million Chinese yuan, Monthly ARPPU for social entertainment declined by 9.7% year over year to 70.4 million Chinese yuan.&nbsp;
Total&nbsp;cash, equivalents, term deposits and short-term investments&nbsp;as of&nbsp;December 31, 2024,&nbsp;were&nbsp;$5.15 billion.
&#8220;With confidence into 2025, we are pleased to announce an annual dividend of approximately&nbsp;$273 million&nbsp;and an expanded share repurchase program of up to&nbsp;$1 billion,&#8221; said Cussion Pang, Executive Chairman.
The company said it has recently authorized a new share repurchase program under which it may repurchase up to&nbsp;$1 billion&nbsp;of its Class A ordinary shares during a 24-month period commencing from&nbsp;March 2025.
For the fiscal year of 2024, the company declared a cash dividend of&nbsp;$0.09&nbsp;per ordinary share, or&nbsp;$0.18&nbsp;per ADS, to holders of record of ordinary shares and ADSs as of the close of business on&nbsp;April 3, 2025.&nbsp;
Price Action: TME shares are trading higher by 3.37% to $13.50 premarket at last check Tuesday.
Read Next:
<ul>
<li><a href="https://in.benzinga.com/media/25/02/43646042/elon-musks-97-4-billion-openai-takeover-bid-reportedly-not-received-by-chatgpt-parent-another-one-of-his-tactics-says-sam-altman" target="_blank" rel="noreferrer noopener">Elon Musk's $97.4 Billion OpenAI Takeover Bid Reportedly Not Received By ChatGPT Parent: ‘Another One Of His Tactics,' Says Sam Altman</a></li>
</ul>
Photo by Antonio Gravante via Shutterstock.

Markets

Tencent Music's Q4 Revenue Beats Street View, But Monthly Active Users Fall Over 3%

Strategy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>), formerly MicroStrategy, has helped bond managers to outperform since the company has issued 0% convertible bonds. According to this analyst, MSTR's "novel strategy" has the potential for great upside in the future.
What Happened: After MSTR established itself as a Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) treasury firm, the company has been issuing 0% convertible bonds and debt to acquire more Bitcoin. The novel thing about the company&#8217;s strategy is that they have issued these debt securities for almost no interest cost. So the BTC purchase is funded without having to actually pay for the interest expense.
"Now, you might think that this is a little bit reckless but it turns out it's a very novel strategy. Because they have created a network value, they are one of the largest holders of bitcoin now. Ultimately, they might become the second largest holder of Bitcoin after the U.S. government," said Tom Lee, the CIO at Fundstrat Capital.
According to Lee, bondholders were buying these bonds because they offered, for the first time, the ability to invest a billion dollars in a bond with Bitcoin exposure.
"These have been incredibly high performing bonds, they've been the best performing bonds, so they've helped bond managers outperform by buying typical corporate bonds but with an upside in crypto. So this works unless Bitcoin itself doesn't have a promising future," said Lee.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Fading <a href="https://twitter.com/fundstrat?ref_src=twsrc%5Etfw">@fundstrat</a> Tom Lee has been a losing game for a very long time&#8230; <a href="https://t.co/WU4m1EjyM4">pic.twitter.com/WU4m1EjyM4</a>
&mdash; Cory Klippsten &#x1f9a2; Swan.com (@coryklippsten) <a href="https://twitter.com/coryklippsten/status/1901641747538837677?ref_src=twsrc%5Etfw">March 17, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/25/03/44370387/fed-put-on-standby-while-trump-put-may-be-kaput-analysts-expect-jerome-powell-to-pivot-to-a-measured-stance-amid-economic-uncertainty" target="_blank" rel="noreferrer noopener">Fed Put On Standby, While Trump Put May Be Kaput? Analysts Expect Jerome Powell To Pivot To A Measured Stance Amid Economic Uncertainty</a>
Why It Matters: The Michael Saylor-led company, which transformed itself five years ago by using the cash on its balance sheet to purchase Bitcoin is no longer valued based on its software business, but it&#8217;s valued as a holder of Bitcoin.
Lee believes that Saylor had done something "brilliant," and that over time, as MSTR accumulates enough Bitcoin, the company would be able to do novel things like lending or securing financial systems with the cryptocurrency.
"MSTR is going to be one of the few companies that has a large holding of Bitcoin that you can actually tap, so I kind of applaud the strategy. I think that there is a lot of upside, as long as Bitcoin goes up, MSTR is likely goes up a lot more," added Lee.
Price Action: MSTR shares have declined 1.91% on a year-to-date basis and it&#8217;s up 95.81% over a year. Its shares were down 3.29% in premarket on Tuesday whereas the exchange-traded fund tracking the Nasdaq 100 index,&nbsp;Invesco QQQ Trust, Series 1 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)&nbsp;was 0.46% lower.
Benzinga's <a href="https://www.benzinga.com/report/MSTR">Edge Rankings</a> show a strong price trend in the medium and long term, whereas the short term trend has been poor. While its momentum ranking has been quite high at 99.97 percentile, its value and growth rankings are extremely poor.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/report/MSTR"><img loading="lazy" decoding="async" width="804" height="135" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/18081348/Strategy-Edge-Rankings.png" alt="" class="wp-image-829294" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/18081348/Strategy-Edge-Rankings.png 804w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/18081348/Strategy-Edge-Rankings-300x50.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/18081348/Strategy-Edge-Rankings-768x129.png 768w" sizes="(max-width: 804px) 100vw, 804px" /></a></figure>
Its consensus price target was $494.93, with a ‘buy' rating, based on the <a href="https://www.benzinga.com/quote/MSTR/analyst-ratings">14 analysts tracked by Benzinga</a>. The price targets ranged from a low of $140 to a high of $690. The three latest ratings from Barclays, Keefe, Bruyette &amp; Woods, and Maxim Group averaged at $493.67, implying a 71.88% upside.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/quote/MSTR/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="386" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/18081416/MSTR-ANR-startegy-1024x386.png" alt="" class="wp-image-829296" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/18081416/MSTR-ANR-startegy-1024x386.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/18081416/MSTR-ANR-startegy-300x113.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/18081416/MSTR-ANR-startegy-768x289.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/18081416/MSTR-ANR-startegy.png 1062w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44374442/tesla-investors-advised-to-fasten-their-seatbelts-as-this-analyst-expects-march-deliveries-to-take-a-hit-its-stil">Tesla Investors Advised To Fasten Their Seatbelts As Analyst Expects March Deliveries To Take A Hit: It&#8217;s Still &#8216;Best-Positioned Company In Physical AI&#8217;</a></li>
</ul>
Photo courtesy: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Market Summary

Bonds

$BTC

MSTR

Michael Saylor's MSTR Provides Bitcoin Exposure To Bondholders With Its 'Novel Strategy:' Tom Lee Says It's Helping 'Bond Managers Outperform' The Market

Barclays analyst Andrew Lazar maintains General Mills (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GIS#NYSE">GIS</a>) with a Equal-Weight and lowers the price target from $68 to $65.

Barclays Maintains Equal-Weight on General Mills, Lowers Price Target to $65

Barclays analyst Blayne Curtis maintains TXNM Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TXNM#NYSE">TXNM</a>) with a Overweight and raises the price target from $56 to $57.

TXNM

Barclays Maintains Overweight on TXNM Energy, Raises Price Target to $57

Barclays analyst Betty Jiang maintains Exxon Mobil (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>) with a Overweight and lowers the price target from $137 to $135.

Barclays Maintains Overweight on Exxon Mobil, Lowers Price Target to $135

SCWO

374Water Announces Successful Treatment And Destruction Of LNAPL-Based PFAS From Impacted Groundwater Samples From US Navy

Barclays analyst Betty Jiang maintains Expand Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXE#NASDAQ">EXE</a>) with a Equal-Weight and lowers the price target from $117 to $115.

Barclays Maintains Equal-Weight on Expand Energy, Lowers Price Target to $115

High Wire Networks Partners With SentinelOne To Provide Managed Detection And Response And Managed Security Services Provider Solutions

Valens Semiconductor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VLN#NYSE">VLN</a>) today announced that it hosted successful interoperability testing with seven other vendors of MIPI A-PHY silicon: Analogix, ESWIN Technology, Motorcomm, OmniVision Technologies, Silergy, SimChip, and Velink. The testing is a key step towards broad adoption of A-PHY in China, where there is already a particularly robust ecosystem of companies developing&nbsp;products around this technology, and signals significant momentum of this technology for the global automotive industry.
MIPI A-PHY is the first standard in the automotive industry for in-vehicle asymmetric high-speed connectivity. Valens is a leader in MIPI A-PHY, offering the first chipsets on the market to comply with the standard and the first to <a href="https://www.valens.com/newsroom/valens-semiconductor-announces-three-automotive-design-wins-from-leading-european-oems-for-its-va7000-mipi-a-phy-chipsets/">achieve design wins</a> with OEMs.
Achieving interoperability is a pivotal milestone in the establishment of an industry standard, backed by a strong ecosystem. This type of standard would increase supply chain security and decrease dependency on vendor pricing. As part of the weeks-long interoperability testing, which took place across multiple events, Valens established A-PHY links with all vendors, indicating strong product maturity for A-PHY silicon.

Global

Valens Semiconductor Announces That It Hosted Interoperability Testing With Seven Other Vendors Of MIPI A-PHY Silicon; Testing Is A Key Step Towards Broad Adoption Of A-PHY In China

Barclays analyst Betty Jiang maintains EOG Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EOG#NYSE">EOG</a>) with a Equal-Weight and lowers the price target from $146 to $144.

Barclays Maintains Equal-Weight on EOG Resources, Lowers Price Target to $144

ALVO

Alvotech And Dr. Reddy's Announce FDA Acceptance Of Biologic License Application For AVT03

ACOG

Alpha Cognition Announces The Official Commercial Launch Of ZUNVEYL, A New Treatment For Mild To Moderate Alzheimer's Disease

JFBR

Jeffs' Brands Closes Acquisition Of Pure NJ Logistics

Press Releases

Genmab to Showcase Strength and Breadth of Comprehensive Epcoritamab-bysp Development Program at 2024 American Society of Hematology (ASH) Annual Meeting

Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Therapy Demonstrates High Response Rates in Clinical Trial of Patients With Relapsed or Refractory (R/R) Follicular Lymphoma (FL)

Investigational Epcoritamab (DuoBody® CD3xCD20) Monotherapy Achieves High Overall and Complete Response Rates in Clinical Trial of Patients With Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) in Preliminary Analysis

Two Data Analyses from Clinical Trials Show Epcoritamab (DuoBody® CD3xCD20) Induces Durable, Complete Responses as Monotherapy and Combination Treatment in Patients With Diffuse Large B-Cell Lymphoma (DLBCL)

Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2024

Genmab Publishes 2024 Annual Report

EPKINLY® (epcoritamab) Approved by Japan Ministry of Health, Labour and Welfare for Additional Indication as a Treatment for Relapsed or Refractory Follicular Lymphoma

Genmab Announces Johnson & Johnson Decision Regarding HexaBody®-CD38

Investigational Rinatabart Sesutecan (Rina-S®) Continues to Show Encouraging Antitumor Activity in Patients with Advanced Ovarian Cancer

Comments

Genmab

Genmab (GMAB) 옵션

Loading...

뉴스

파트너 / 기고자

벤징가 글로벌